Coya Therapeutics Inc.

06/25/2026 | Press release | Distributed by Public on 06/25/2026 15:00

Proxy Results (Form 8-K)

Item 5.07

Submission of Matters to a Vote of Security Holders.

On June 25, 2026, Coya Therapeutics, Inc. (the "Company") held its Annual Meeting of Stockholders (the "Annual Meeting"). The matters voted on at the Annual Meeting were: (i) the election of two Class I directors and (ii) the ratification of the appointment of Weaver and Tidwell, L.L.P. as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. The final voting results were as follows:

1. The election of Secretary Wilbur Ross and Dieter Weinand, as Class I directors to hold office for a term of three years, until their successors are duly elected and qualified or they are otherwise unable to complete their respective terms. The votes were cast for this matter were as follows:

Nominee

For Withheld Broker Non-Votes

Secretary Wilbur Ross

 9,168,496 2,818,233 4,585,732

Dieter Weinand

10,566,702 1,420,027 4,585,732

2. The proposal to ratify the appointment of Weaver and Tidwell, L.L.P. as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 was approved based upon the following votes:

For Against Abstain
16,545,887 22,661 3,913
Coya Therapeutics Inc. published this content on June 25, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on June 25, 2026 at 21:00 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]